You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Desvenlafaxine Succinate

Showing 1 - 25 of 219
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Beijing (Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule

Completed
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule Placebo
  • +3 more
  • Beijing, China
    Beijing Anding Hospital
Dec 1, 2021

Depressive Disorder, MDD Trial in United States (Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR))

Completed
Has Results
  • Depressive Disorder, Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
  • Little Rock, Arkansas
  • +8 more
Aug 17, 2021

Hot Flashes, Breast Tumors Trial in Goyang, Seongnam, Seoul (Desvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg,

Terminated
  • Hot Flashes
  • Breast Neoplasms
  • Desvenlafaxine succinate 100mg
  • +2 more
  • Goyang, Gyeonggi-do, Korea, Republic of
  • +2 more
Sep 18, 2019

MDD Trial in Tokyo (Desvenlafaxine 100 mg, Desvenlafaxine 50 mg, Placebo)

Completed
  • Major Depressive Disorder
  • Desvenlafaxine 100 mg
  • +2 more
  • Tokyo, Japan
    Mochida Investigational sites
Sep 28, 2022

Study to Explore Antidepressant Treatment in Korea

Completed
  • Major Depression
  • Seoul, Korea, Republic of
    Pfizer
Nov 14, 2022

MDD Trial in Worldwide (Vortioxetine, Desvenlafaxine)

Completed
  • Major Depressive Disorder
  • Banfield, Buenos Aires, Argentina
  • +79 more
Feb 11, 2022

MDD Trial in Japan (desvenlafaxine succinate sustained release tablets)

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release tablets
  • Aichi, Japan
  • +16 more
Nov 15, 2018

Generalized Anxiety Disorder Trial in Toronto (Desvenlafaxine)

Completed
  • Generalized Anxiety Disorder
  • Toronto, Ontario, Canada
    START Clinic for Mood and Anxiety Disorders
Oct 21, 2020

MDD, Neuroticism, Cognitive Change Trial in Farmington (Sertraline, bupropion, desvenlafaxine)

Recruiting
  • Major Depressive Disorder
  • +3 more
  • Sertraline, bupropion, desvenlafaxine
  • Farmington, Connecticut
    UConn Health
Mar 10, 2022

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Depressive Disorder, Major Trial in United States (SAGE-217, Matching Placebo, Sertraline)

Completed
  • Depressive Disorder, Major
  • Dothan, Alabama
  • +50 more
Feb 28, 2022

Depression, Opioid Dependence, Methadone Treatment Trial in Montréal (Desvenlafaxine)

Completed
  • Depression
  • +2 more
  • Montréal, Quebec, Canada
    Centre de recherche du Centre Hospitalier de l'Université de Mon
Oct 21, 2020

Depression, Anhedonia Trial in Toronto (Desvenlafaxine)

Completed
  • Depression
  • Anhedonia
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Oct 28, 2020

Bipolar Disorder Therapies

Completed
  • Bipolar Disorder
  • Lithium Carbonate
  • +29 more
  • Albuquerque, New Mexico
    Christophe G Lambert
Sep 29, 2021

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
  • +3 more
  • (no location specified)
Mar 2, 2023

Overactive Bladder Trial in Shanghai (electroacupuncture, Solifenacin Succinate Tablets)

Not yet recruiting
  • Overactive Bladder
  • electroacupuncture
  • Solifenacin Succinate Tablets
  • Shanghai, Shanghai, China
    Longhua Hospital Shanghai University of Traditional Chinese Medi
Mar 23, 2023

Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

Completed
  • Gastric Cancer
  • Arm I : Experimental (Prucalopride succinate group)
  • Arm II : Control (Mosapride citrate group)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jul 21, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

Not yet recruiting
  • End-Stage Kidney Disease
  • End-Stage Renal Disease
  • Boston, Massachusetts
  • +4 more
Jun 26, 2023

Overactive Bladder, Benign Prostate Hyperplasia, Transurethral Resection of Prostate Trial in Soul (Solifenacin Succinate,

Completed
  • Overactive Bladder
  • +3 more
  • Solifenacin Succinate
  • Placebo
  • Soul, Korea, Republic of
    (unnamed)
Jul 26, 2022

Assay to Measure Beta Blocker Adherence

Recruiting
  • Congestive Heart Failure
  • Medication Adherence
  • Quest beta blocker assay
  • Akron, Ohio
    Summa Health System
Mar 4, 2022

Overactive Bladder in Parkinson's Disease Trial in Miami, Tampa, Atlanta (solifenacin succinate (VESIcare), )

Completed
Has Results
  • Overactive Bladder in Parkinson's Disease
  • solifenacin succinate (VESIcare)
  • placebo
  • Miami, Florida
  • +2 more
Nov 8, 2021

MDD Trial in Baltimore (LY03005)

Completed
  • Major Depressive Disorder
  • Baltimore, Maryland
    Pharmaron CPC, Inc.
Aug 5, 2019

Nausea and Vomiting of Pregnancy Trial in United States (doxylamine succinate 10 mg/pyridoxine HCl 10 mg, Placebo)

Completed
Has Results
  • Nausea and Vomiting of Pregnancy
  • doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg
  • Placebo
  • Washington, District of Columbia
  • +6 more
Nov 22, 2021